A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Moiseenko, Vitali ^a   Song, William Y ^b   Mell, Loren K ^b   Bhandare, Niranjan ^c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; DOSE RESPONSE; GEOMETRY; INCIDENCE; MAXIMUM LIKELIHOOD METHOD; NTCP MODEL; POISSON DISTRIBUTION; RADIATION DOSE; RADIATION INDUCED OPTIC NERVE DISEASE; RADIATION INDUCED RETINOPATHY; RADIATION INJURY; RETINA INJURY; VISUAL SYSTEM EXAMINATION; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; EYE; HUMAN; METHODOLOGY; OPTIC NERVE DISEASE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOTHERAPY; REGRESSION ANALYSIS; RETINA; RETINA DISEASE; STATISTICAL MODEL;

COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; EYE; HUMANS; LIKELIHOOD FUNCTIONS; OPTIC NERVE DISEASES; POISSON DISTRIBUTION; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REGRESSION ANALYSIS; RETINA; RETINAL DISEASES;

EID: 79957894506     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-61     Document Type: Article

References (35)

1. Niemierko A, Urie M, Goitein M. Optimization of 3D radiation therapy with both physical and biological end points and constraints. Int J Radiat Oncol Biol Phys 1992, 23:99-108. 10.1016/0360-3016(92)90548-V, 1572836.
2. Sodertrom S, Brahme A. Optimization of the dose delivery in a few field techniques using radiobiological objective functions. Med Phys 1993, 20:1201-1210. 10.1118/1.596971, 8413030.
3. Alber M, Nusslin F. An objective function for radiation treatment optimization based on local biological measures. Phys Med Biol 1999, 44:479-493. 10.1088/0031-9155/44/2/014, 10070796.
4. Semenenko VA, Reitz B, Day E, Qi XS, Miften M, Li XA. Evaluation of a commercial biologically based IMRT treatment planning system. Med Phys 2008, 35:5851-5860. 10.1118/1.3013556, 19175141.
5. Yang Y, Xing L. Towards biologically conformal radiation therapy (BCRT): selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys 2005, 32:1473-1484. 10.1118/1.1924312, 16013703.
6. Kim Y, Tome W. Optimization of radiotherapy using biological parameters. Cancer Treat Res 2008, 139:257-278.
7. South CP, Partridge M, Evans PM. A theoretical framework for prescribing radiotherapy dose distributions using patient-specific biological information. Med Phys 2008, 35:4599-4611. 10.1118/1.2975229, 18975706.
8. Yorke ED. Modeling the effects of inhomogeneous dose distributions in normal tissues. Semin Radiat Oncol 2001, 11:197-209. 10.1053/srao.2001.23478, 11447576.
9. Kallman P, Agren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol 1992, 62:249-262. 10.1080/09553009214552071, 1355519.
10. Lyman JT, Wolbarst AB. Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm. Int J Radiat Oncol Biol Phys 1989, 17:433-436. 10.1016/0360-3016(89)90462-8, 2753766.
11. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 1995, 32:1227-1237. 10.1016/0360-3016(94)00475-Z, 7607946.
12. Schultheiss TE, Orton CG, Peck RA. Models in radiotherapy: volume effects. Med Phys 1983, 10:410-415. 10.1118/1.595312, 6888354.
13. Wu Q, Mohan R, Niemierko A, Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 2002, 52:224-235. 10.1016/S0360-3016(01)02585-8, 11777642.
14. Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 2003, 55:724-735. 10.1016/S0360-3016(02)03986-X, 12573760.
15. Sohn M, Yan D, Liang J, Meldolesi E, Vargas C, Alber M. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 2007, 67:1066-1073. 10.1016/j.ijrobp.2006.10.014, 1991336, 17258870.
16. Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 1997, 71:531-542. 10.1080/095530097143860, 9191898.
17. Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010, 76:S10-S19. 10.1016/j.ijrobp.2009.07.1754, 20171502.
18. Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010, 76:S58-S63. 10.1016/j.ijrobp.2009.06.090, 20171519.
19. Munter MW, Karger CP, Hoffner SG, Hof H, Thilmann C, Rudat V, et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 2004, 58:175-184. 10.1016/S0360-3016(03)01437-8, 14697436.
20. Munter MW, Hoffner S, Hof H, Herfarth KK, Haberkorn U, Rudat V, et al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys 2007, 67:651-659. 10.1016/j.ijrobp.2006.09.035, 17175118.
21. Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM. Does altered fractionation influence the risk of radiation-induced optic neuropathy?. Int J Radiat Oncol Biol Phys 2005, 62:1070-1077. 10.1016/j.ijrobp.2004.12.009, 15990010.
22. Monroe AT, Bhandare N, Morris CG, Mendenhall WM. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys 2005, 61:856-864. 10.1016/j.ijrobp.2004.07.664, 15708266.
23. Bhandare N, Song W, Moiseenko V, Malyapa R, Morris CG, Mendenhall WM. Radiation-induced optic neuropothy: dose response and modeling total dose and fractionation. International Journal of Radiation Oncology Biology Physics 2008, 72(1):S396. Ref Type: Abstract.
24. Song W, Bhandare N, Moiseenko V. Dose Response Analysis of Radiation-Induced Retinopathy (RIRP) Single-Institution Data Using the Lyman NTCP Model. Med Phys 2008, 35(6):2934. Ref Type: Abstract.
25. Thames HD, Rozell ME, Tucker SL, Ang KK, Fisher DR, Travis EL. Direct analysis of quantal radiation response data. Int J Radiat Biol Relat Stud Phys Chem Med 1986, 49:999-1009. 10.1080/09553008514553221, 3486855.
26. Roberts SA, Hendry JH. The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data. Radiother Oncol 1993, 29:69-74. 10.1016/0167-8140(93)90175-8, 8295990.
27. Agresti A, Coull B. Approximate is better than "exact" for interval estimation of binomial proportions. The American Statistician 1998, 52:119-126.
28. Langer M, Morrill SS, Lane R. A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities. Int J Radiat Oncol Biol Phys 1998, 41:451-457. 10.1016/S0360-3016(98)00057-1, 9607364.
29. Zaider M, Amols HI. A little to a lot or a lot to a little: is NTCP always minimized in multiport therapy?. Int J Radiat Oncol Biol Phys 1998, 41:945-950. 10.1016/S0360-3016(98)00128-X, 9652862.
30. Moiseenko V, Battista J, van Dyk J. Normal tissue complication probabilities: dependence on choice of biological model and dose-volume histogram reduction scheme. Int J Radiat Oncol Biol Phys 2000, 46:983-993. 10.1016/S0360-3016(99)00473-3, 10705021.
31. Claus F, De Gersem W, Vanhoutte I, Duthoy W, Remouchamps V, De Wagter C, et al. Evaluation of a leaf position optimization tool for intensity modulated radiation therapy of head and neck cancer. Radiother Oncol 2001, 61:281-286. 10.1016/S0167-8140(01)00441-8, 11730998.
32. Wigg DR. Applied Radiobiology and Bioeffect Planning 2001, Madison, Wisconsin: Medical Physics Publishing, 1.
33. Witte MG, van der GJ, Schneider C, Lebesque JV, Alber M, van Herk M. IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP. Med Phys 2007, 34:3544-3555. 10.1118/1.2760027, 17926957.
34. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys 1989, 16:1623-1630. 10.1016/0360-3016(89)90972-3, 2722599.
35. Dawson LA, Eccles C, Craig T. Individualized image guided iso-NTCP based liver cancer SBRT. Acta Oncol 2006, 45:856-864. 10.1080/02841860600936369, 16982550.